Introduction {#s6}
============

Combustible cigarette smoking among high school students has declined to its lowest level since 1991,^[@CIT0001]^ however use of alternative tobacco products, such as electronic cigarette (e-cigarette) and hookah (tobacco water pipe) has increased in recent years.^[@CIT0002],[@CIT0003]^ The widespread availability of conventional and alternative tobacco products has resulted in numerous, dynamic patterns of polytobacco product use (ie, use of three or more tobacco products) among youth.^[@CIT0004]^ In 2015, 13.0% of high school students used two or more tobacco products in the past 30 days,^[@CIT0004]^ and 64.6% of past 30-day e-cigarette users and 83.9% of past 30-day cigarette users, respectively, were polytobacco users.^[@CIT0008]^

The numerous configurations of polyproduct use patterns pose a challenge to tobacco control efforts, as it is unclear which forms of polyproduct use should garner the highest priority. Identifying a more parsimonious set of common, homogenous tobacco use patterns can identify particular forms of poly use that can be targeted in prevention programs, policies, and surveillance. The small body of evidence to date suggests that there are distinct groups of adolescents who temporarily experiment with multiple tobacco products as well as others who may use one or more products across multiple time points.^[@CIT0009]^ Previous research investigating youth tobacco product use trajectories has typically focused on a single tobacco product at a time,^[@CIT0012]^ and there is little longitudinal research assessing complex developmental patterns of polytobacco use throughout adolescence. Person-centered statistical approaches, such as parallel process latent growth mixture modeling (GMM), which parsimoniously account for heterogeneity in the use and co-use patterns of multiple tobacco products over time, are needed to identify homogeneous subgroups of adolescents with similar longitudinal patterns of change in use and co-use of multiple tobacco products across adolescence.^[@CIT0013]^

Identifying prototypical patterns of polytobacco use across adolescence is also important for understanding which configurations of polytobacco use patterns may be associated with adverse health outcomes. Tobacco product use among high school students has been shown to be associated with the use of alcohol and other illicit substances,^[@CIT0014]^ with the level or prevalence of substance use increasing proportionally with the number of tobacco products used.^[@CIT0015]^ Recent cross-sectional data suggests that polytobacco use is associated with increased likelihood of alcohol and marijuana use^[@CIT0016]^ and mental health symptomology (ie, depression and anxiety).^[@CIT0019]^ Additionally, prospective data indicates that more frequent e-cigarette and combustible cigarette use may also be associated with increased severity of depressive symptomology.^[@CIT0020],[@CIT0021]^ However, it is unknown if specific polytobacco use trajectories are longitudinally associated with increases in substance use and mental health problems during mid-adolescence.

In this longitudinal study of Los Angeles area high school students, we examined heterogeneity in developmental patterns of polytobacco use across ages 14 to 16 years and identify profiles with distinct trajectories of use and co-use of the three tobacco products that are currently most popular among adolescents (ie, combustible cigarette, e-cigarette, and hookah).^[@CIT0003]^ We also examine prospective associations of polytobacco use trajectories with substance use (ie, alcohol, marijuana, and illicit drugs) and mental health problems (ie, depression, anxiety, and attention deficit/hyperactivity disorder \[ADHD\]). Such data can inform product-specific targets for tobacco prevention interventions among youth who experiment with and regularly use popular tobacco products, and may also elucidate polytobacco use trajectories that confer risk for subsequent substance use and mental health problems.

Methods {#s7}
=======

Sample and Procedure {#s8}
--------------------

Data were drawn from the Happiness & Health Study, a longitudinal cohort survey of substance use and mental health among high school students in the Los Angeles metropolitan area.^[@CIT0022]^ Forty public high schools were approached to participate in the study due to their demographic characteristics, proximity, and willingness to participate in research; 10 schools agreed to participate in the study (see [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for characteristics of participating schools in reference to Los Angeles county public schools).

Of the 4100 eligible 9th grade students, 3396 students and their parents provided active written or verbal assent and consent, respectively, to enroll in the study. Data collection involved five semiannual assessments: baseline (fall 9th grade, 2013; *N* (surveyed) = 3383, 99.6%), 6-month (spring 9th grade, 2014; *N* = 3292, 96.9%), 12-month (fall 10th grade, 2014; *N* = 3281, 96.6%), 18-month (spring 10th grade, 2015; *N* = 3251, 95.7%), and 24-month (fall 11th grade, 2015; *N* = 3232, 95.2%) follow-ups. At each assessment, paper-and-pencil surveys were administered onsite in students' classrooms. Students not in class during data collections completed surveys by telephone, Internet, or mail (6-month follow-up: *N* = 49, 12-month follow-up: *N* = 142, 18-month follow-up: *N* = 216, 24-month follow-up: *N* = 247). The University of Southern California Health Sciences Review Board approved this study.

Measures {#s9}
--------

### Tobacco Product Use {#s10}

At each assessment, items based on the Youth Behavior Risk Surveillance (YRBS)^[@CIT0023]^ and Monitoring the Future (MTF)^[@CIT0003]^ surveys assessed the past 6-month use of combustible cigarettes (described as even a few-puffs), e-cigarettes, and hookah. Use of each tobacco product was dichotomously coded as 0 (No) and 1 (Yes) to indicate the prevalence of past 6-month use of each product.

### Substance Use Outcomes {#s11}

At the baseline and 24-month assessments, past 30-day use of alcohol ("one full drink of alcohol and not just a few sips for religious purposes"), marijuana, and other illicit drugs (eg, illicit and prescription stimulants, prescription painkillers) were measured using well-validated items assessing the number of days used each substance was used in the past 30 days (forced choice with 9 ordinal options ranging from 1 \[0 days\] to 9 \[all 30 days\]).^[@CIT0023]^ These response categories were recoded into quantitative count variables by taking the mean value of each ordinal category: 0 (0 days), 2 (1--2 days), 4 (3--5 days), 8 (6--9 days), 12 (10--14 days), 17 (15--19 days), 22 (20--24 days), 27 (25--29 days), and 30 (all 30 days).

### Mental Health Outcomes {#s12}

At the baseline and 24-month assessments, depressive symptomology was assessed with the Center for Epidemiologic Studies Depression Scale (CESD).^[@CIT0024]^ The CESD is a 20-item measure of depressive symptoms experienced over the past week, rated on a 4-point Likert scale, ranging from 0 (Rarely or None of the time; 0--1 days) to 3 (Most or all of the time; 5--7 days). The total sum score of the 20 items was computed (Cronbach's αs = .81 and .83 for baseline and 24-month follow-up, respectively) and was dichotomized (yes/no) based on the measure's recommended cutoff for clinical depression.^[@CIT0025]^ The Revised Children's Anxiety and Depression Scale (RCADS)^[@CIT0026]^ was used to assess respondents' generalized anxiety. Raw sum scores of six items (αs\>.89) were converted into gender- and age-normed standardized *T*-scores and were dichotomously coded for the borderline clinical cutoff of the Generalized Anxiety Disorder (GAD). The 18-item Current Symptoms Scale-Self Report Form measure of DSM-IV ADHD^[@CIT0027]^ assessed current ADHD symptoms (αs \> .92), with nine items measuring the inattention and hyperactivity-impulsivity symptom dimensions of ADHD. Respondents rated how frequently they experienced each individual symptom during the past 6 months from 0 (never or rarely) to 3 (very often). If 12 or more items were endorsed at ratings of 2 or higher, ADHD was dichotomously coded above clinical cutoff. Because ADHD measures were not added to the assessment battery until the 6-month follow-up assessment, the ADHD score at the 6-month follow-up was used as the baseline score for this analysis.

### Covariates {#s13}

*A priori* covariates were selected based on their association with tobacco use or mental health outcomes in the extant literature.^[@CIT0028],[@CIT0029]^ At baseline, time-invariant sociodemographic covariates including age, gender, race/ethnicity, and highest parental education level were assessed with investigator-defined forced-choice items (see response categories in [Table 1](#T1){ref-type="table"}). Past 6-month use of other tobacco products (ie, smokeless tobacco, cigars, cigarillos, dissolvable) at baseline was assessed with four items from the YRBS and MTF studies. This other tobacco use covariate was dichotomously coded (0 = no use; 1 = any use of other forms of tobacco).

###### 

Sample Characteristics at Baseline by Polytobacco Use Trajectory Groups

                                                             Multiple tobacco product trajectory groups                                     
  ------------------------------------------- -------------- -------------------------------------------- ---------------- ---------------- --------
  ***Sociodemographics/Other tobacco use***                                                                                                 
  Sex^a^                                      3393 (100.0)   182 (100.0)                                  920 (100.0)      2291 (100.0)     .15
   Female                                     1811 (53.4)    95 (52.2)                                    467 (50.8)       1249 (54.5)      
   Male                                       1582 (46.6)    87 (47.8)                                    453 (49.2)       1042 (45.5)      
  Age^b^                                      14.58 (.40)    14.56 (.41)^f^                               14.63 (.41)^f^   14.55 (.40)^f^   \<.001
  Race/ethnicity^a^                           3310 (100.0)   173 (100.0)                                  895 (100.0)      2242 (100.0)     \<.001
   White                                      520 (15.7)     29 (16.8)                                    129 (14.4)       362 (16.1)       
   Hispanic                                   1557 (47.0)    96 (55.5)                                    492 (55.0)       969 (43.2)       
   Black                                      165 (5.0)      4 (2.3)                                      44 (4.9)         117 (5.2)        
   Asian                                      535 (16.2)     12 (6.9)                                     87 (9.7)         436 (19.4)       
   Other                                      533 (16.1)     32 (18.5)                                    143 (16.0)       358 (16.0)       
  Parental education level^a,\ c^             2491 (100.0)   125 (100.0)                                  665 (100.0)      1701 (100.0)     \<.001
   ≤8^th^ grade                               76 (3.1)       4 (3.2)                                      21 (3.2)         51 (3.0)         
   Some high school                           204 (8.2)      13 (10.4)                                    77 (11.6)        114 (6.7)        
   High school graduate                       393 (15.8)     25 (20.0)                                    125 (18.8)       243 (14.3)       
   Some college                               491 (19.7)     30 (24.0)                                    141 (21.2)       320 (18.8)       
   College graduate                           818 (32.8)     36 (28.8)                                    201 (30.2)       581 (34.2)       
   Graduate degree                            509 (20.4)     17 (13.6)                                    100 (15.0)       392 (23.0)       
  Other tobacco products use^a^               3359 (100.0)   179 (100.0)                                  907 (100.0)      2273 (100.0)     \<.001
   No use                                     3243 (96.5)    135 (75.4)                                   844 (93.1)       2264 (99.6)      
   Any use                                    116 (3.5)      44 (24.6)                                    63 (6.9)         9 (0.4)          

^a^Available (nonmissing) data for respective variable and, for categorical variables, denominator for within-column percentages. *n* (%). Based on χ^2^ test of association. ^b^Mean (*SD*). Based on the ANOVA test of association. ^c^Participants who marked "don't know" response (*N* = 422) recoded as missing. ^d^Escalating Cigarette & e-Cigarette / High Hookah. ^e^Escalating cigarette / Decreasing e-cigarette & hookah. ^f^LSD post hoc analyses results.

Analytic Plan {#s14}
-------------

To characterize trajectories of past 6-month combustible cigarette, e-cigarette, and hookah use across the first four assessments, we conducted a series of growth mixture modeling (GMM) analyses---an analytic technique that allows for the estimation of subgroups of individuals within the population who differ in terms of their initial levels and rates of change for a specific outcome over time.^[@CIT0013]^ We utilized a "parallel process" application of GMM, which generates classes based on covariation across three separate sets of latent intercepts and linear slopes (ie, one set of growth factors per tobacco product).^[@CIT0030]^ The number of classes that best fit the data for the three tobacco use outcomes was selected based on model fit comparisons using a series of standard fit indices: Bayesian Information Criterion (BIC), sample-size-adjusted BIC (SSA-BIC), Akaike Information Criterion (AIC), Lo--Mendell--Rubin (LMR) likelihood ratio test, and entropy.^[@CIT0031]^ Optimal models were chosen on the basis of goodness of fit and parsimony.

After identifying the polytobacco use trajectory profiles, participants were assigned to their most probable trajectory class. We then utilized regression modeling to test associations of polytobacco use trajectory class memberships across baseline to 18-month follow-up with substance use and mental health outcomes at the 24-month follow-up, with separate models for each outcome. As the substance use outcomes (ie, the number of days each substance was used in the past 30 days) were zero-inflated and over-dispersed, we utilized negative binomial regression modeling for these outcomes.^[@CIT0032]^ The negative binomial regression coefficients were exponentiated to obtain incidence rate ratios (*IRR*s). Binary logistic regression modeling was applied for each mental health outcome (dichotomously coded above or below clinical cutoff). For all tests, we controlled for the aforementioned sociodemographic covariates and each respective substance use or mental health outcome at baseline.

All analyses were conducted in Mplus^[@CIT0033]^ version 7 with statistical significance set at *p* \< .05. As respondents were clustered within schools, a complex analysis was used to adjust parameter standard errors for interdependence in the data (ie, the error terms of regression models were not independent) to avoid an underestimation of standard errors. Missing data were managed with full information likelihood estimation (FIML).

Results {#s15}
=======

Preliminary Analyses {#s16}
--------------------

Among study enrollees, 3393 students provided at least one data point for the tobacco product use outcomes in the primary GMM analyses (99.9%), and were included in the analytic sample (see [Table 1](#T1){ref-type="table"} for Ns of available data). We first examined differences in study variables among participants who completed (*N* = 3232, 95.2%) and did not complete (*N* = 164, 4.8%) the 24-month follow-up. No significant differences among study variables between these two groups were detected (*p*s = .07−.42). As depicted in [Table 1](#T1){ref-type="table"}, the sample was balanced on gender and was sociodemographically diverse. The prevalence of past 6-month tobacco use in each assessment is presented in [Supplementary Table S2](#sup1){ref-type="supplementary-material"} of the online supplemental materials. Also, the prevalence of substance use and mental health symptomology outcomes at baseline is presented in [Supplementary Table S3](#sup1){ref-type="supplementary-material"} of the online supplemental materials.

Trajectory Groups of Combustible Cigarette, E-cigarette, and Hookah Use {#s17}
-----------------------------------------------------------------------

Fit indices for parallel GMM analyses (presented in [Table 2](#T2){ref-type="table"}) converged to suggest the superiority of a three-class solution fitting the data best (SSA-BIC = 22040.438; Entropy = 0.850; LMR *p* = .014). [Figure 1](#F1){ref-type="fig"} presents the observed trajectories of polytobacco product use prevalence across assessments after individuals were assigned to each respective group. Approximately 67.5% of adolescents were identified as the "Tobacco nonusers" group (*N* = 2291). Tobacco nonusers reported a negligible prevalence of combustible cigarette, e-cigarette, and hookah use in the past 6 months at each assessment (\<3%), and their prevalence of use of each tobacco product did not significantly change during the study observation period (see [Figure 1](#F1){ref-type="fig"}).

###### 

Fit Indices for Growth Mixture Models

  Class \#   AIC             BIC             SSA-BIC         Entropy     LMR *p*
  ---------- --------------- --------------- --------------- ----------- ------------
  1          26759.696       26796.473       26777.408       ---         ---
  2          22446.874       22526.557       22485.250       0.825       0.0001
  **3**      **21981.398**   **22103.988**   **22040.438**   **0.850**   **0.0144**
  4          21901.071       22066.567       21980.775       0.816       0.5705
  5          21831.845       22040.247       21932.213       0.804       0.5592

AIC = Akaike Information Criterion. BIC = Bayesian Information Criterion. SSA-BIC = sample-size-adjusted BIC. LMR *p* = The Lo--Mendell--Rubin (LMR) likelihood ratio test *p* value.

![Observed trajectories of combustible cigarette, e-cigarette, and hookah use by three groups. *N* = 3393. W1 = Baseline (Mean age = 14 years). W2 = 6-month follow-up. W3 = 12-month follow-up. W4 = 18-month follow-up. The significance of slope mean estimate of each tobacco product use is indicated in the legends: \**p* \< 0.05, \*\**p* \< 0.01. ^a^Chronic polyproduct users: Escalating cigarette & e-cigarette / High stable hookah (*N* = 182, 5.4%). ^b^Polyproduct users: Escalating cigarette / Decreasing e-cigarette & hookah (*N* = 920, 27.1%). ^c^Tobacco nonusers (*N* = 2291, 67.5%).](ntx27001){#F1}

The "Polyproduct users" group (*N* = 920, 27.1%) displayed disparate trajectories of combustible cigarette use and alternative tobacco product (ie, e-cigarette, hookah) use. Polyproduct users displayed a low prevalence of combustible cigarette use at baseline (7.7%), but their prevalence of combustible cigarette use significantly increased over follow-up, reaching 19.9% at the 18-month follow-up (Slope mean = 0.176, *p* \< .001). However, their prevalence of e-cigarette use significantly decreased from 32.5% to 20.8% and their prevalence of hookah use significantly decreased from 27.1% to 17.2% from baseline to the 18-month follow-up assessment (Slope mean = −0.085, *p* = 0.02 for e-cigarette; Slope mean = −0.157, *p* = 0.01 for hookah).

The "Chronic polyproduct users" group was comprised of 182 adolescents (5.4%) who displayed the highest prevalence of use of each tobacco product at baseline and significantly increased their prevalence of combustible cigarette use (Slope mean = 0.355, *p* \< .001) and e-cigarette use (Slope mean = 0.389, *p* \< .001) across the follow-up period. Their prevalence of combustible cigarette use increased from 38.2% at baseline to 67.8% at the 18-month follow-up, and their prevalence of past 6-month e-cigarette use increased from 58.9% at baseline to 83.3%. The prevalence of hookah use in this group increased from 45.8% to 60.4% across the follow-ups, but the change over time was not significantly different from zero (Slope mean = 0.138, *p* = .19).

Associations of Polytobacco Use Trajectory Groups With Substance Use and Mental Health {#s18}
--------------------------------------------------------------------------------------

[Table 3](#T3){ref-type="table"} presents the associations of polytobacco use trajectory groups with changes in substance use and mental health outcomes from baseline to the 24-month follow-up. Compared with Tobacco nonusers, Chronic polyproduct users and Polyproduct users used alcohol, marijuana, and other illicit drugs a greater number of days at the 24-month follow-up after adjusting for respective baseline levels and demographics (*p*s \< .01; [Table 3](#T3){ref-type="table"}). Also, Chronic polyproduct users, compared with Polyproduct users, reported significantly more days of alcohol (IRR \[95%CI\] = 1.90 \[1.14, 2.67\]; *p* = .004), marijuana (IRR \[95%CI\] = 2.16 \[1.50, 2.82\]; *p* \< .001), and other illicit drug use (IRR \[95%CI\] = 2.37 \[1.60, 3.14\]; *p* \< 0.001) at follow-up. In [Table 3](#T3){ref-type="table"}, we present IRR estimates for each substance use outcome and polytobacco use trajectory group contrast.

###### 

Associations of Polytobacco Use Trajectory Groups With Substance Use and Mental Health Outcomes at 24-Month Follow-Up

  Outcomes (W5)                    Tobacco use trajectory groups                                                               
  -------------------------------- ------------------------------- --------------- ------------- --------------- ------------- --------------
  ***Past month substance use***   IRR                             95% CI          IRR           95% CI          IRR           95% CI
   Alcohol use                     5.632^\*\*^                     2.775, 8.489    3.524^\*\*^   2.888, 4.160    1.902^\*\*^   1.138, 2.667
   Marijuana use                   7.425^\*\*^                     2.512, 12.338   5.344^\*\*^   2.256, 8.431    2.159^\*\*^   1.498,2.820
   Other illicit drug use          9.286^\*\*^                     5.424, 13.148   7.485^\*\*^   3.292, 11.677   2.366^\*\*^   1.598, 3.135
  ***Mental health outcomes***     OR                              95% CI          OR            95% CI          OR            95% CI
   Depression (CESD)               1.469^\*\*^                     1.146, 1.792    1.334^\*\*^   1.080, 1.588    1.101         0.714, 1.488
   Anxiety (RCADS-GAD)             1.572^\*\*^                     1.133, 2.011    1.236^\*^     1.043, 1.426    1.127         0.984, 1.277
   ADHD                            2.597^\*\*^                     1.830, 3.364    1.394^\*^     1.053, 1.735    1.663^\*\*^   1.272, 2.054

*N* = 3393. IRR = Incidence Rate Ratio. OR = Odds Ratio. CI = Confidence Interval. Adjusted for parental education level, youth age, gender, ethnicity, other tobacco products use (eg, smokeless tobacco, cigars/cigarillos, dissolvable) in the past 6 months, and each outcome indicator at baseline. W5 = 24-month follow-up. Mental health outcomes were coded by 0 = Scores below the clinical cutoff and 1 = Scores above the clinical cutoff. Past month substance use outcomes were coded as a count variable indicating number of days of substance use in the past month. ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01.

Chronic polyproduct users and Polyproduct users (vs. Tobacco nonusers) were more likely to report depression, anxiety, and ADHD symptoms that reached the clinical cutoff at the 24-month follow-up, after controlling for sociodemographic factors and baseline mental health problems ([Table 3](#T3){ref-type="table"}). For instance, compared to Tobacco nonusers, the odds of Chronic polyproduct users reporting symptoms that reached the clinical cutoff for depression at the final follow-up were 47% higher (OR \[95%CI\] = 1.47 \[1.15, 1.79\]; *p* \< .001). Compared with Polyproduct users, Chronic polyproduct users were 66% more likely to report ADHD symptoms that reached the clinical cutoff (OR \[95%CI\] = 1.66 \[1.27, 2.05\], *p* \< .01); however, they were not significantly more likely to report clinical symptoms of depression (OR \[95%CI\] = 1.10 \[0.71, 1.49\], *p* = .58) or generalized anxiety (OR \[95%CI\] = 1.13 \[0.98, 1.28\]; *p* = .43). [Table 3](#T3){ref-type="table"} presents OR estimates for each mental health outcome and tobacco product use trajectory group contrast.

Sensitivity Analyses {#s19}
--------------------

A series of sensitivity analyses were conducted to assess if the results remained consistent when different subsets of the sample were excluded. Associations of polytobacco use trajectory groups with changes in substance use and mental health outcomes from baseline to the 24-month follow-up did not differ when: (1) students (*N* = 55, 1.6%) whose reports were of questionable validity were removed (eg, reported use of a fictitious drug); (2) students (*N* = 377, 11.1%) who completed a follow-up survey by an alternate mode of survey administration other than in-class paper surveys (ie, telephone, internet, or mail) were removed; and (3) only the subsample of students (*N* = 3082, 90.8%) who completed all five assessments were included (see supplemental materials). We did not find any meaningful differences from the results using the total sample (*N* = 3393).

Discussion {#s20}
==========

To our knowledge, this is the first study to provide a parsimonious characterization of the broad variation in use and co-use of popular tobacco products across an important developmental period of risk (ie, mid-adolescence). Using an empirically derived modeling approach, this study identified three profiles with distinct trajectories that explained the heterogeneity in developmental patterns of use and poly use of tobacco products among adolescents: (1) Chronic polyproduct users; (2) Polyproduct users; and (3) Tobacco nonusers. A key finding from this analysis is that prototypical patterns of use of tobacco products across mid-adolescence in this sample either involve the use of no products or some form of polytobacco product use. A single product user trajectory was not identified in the data. Hence, poly use is the norm and single product use is the exception, suggesting that a comprehensive approach to tobacco control in adolescents that addresses multiple products is warranted.

Consistent with results from national surveys,^[@CIT0003]^ the majority of youth in this sample (67.5%) did not use any tobacco products, or had a negligible prevalence of past 6-month combustible cigarette, e-cigarette, and hookah use across mid-adolescence. Youth in the Chronic polyproduct and Polyproduct user groups displayed distinct patterns in their polytobacco use trajectories. Chronic polyproduct users (approximately 5% of the sample) had the highest prevalence of past 6-month combustible cigarette, e-cigarette, and hookah use at each assessment with escalating trajectories of combustible cigarette (38% to 68% across follow-up) and e-cigarette use (59% to 83% across follow-up) during mid-adolescence. These youths may reflect those whose tobacco product consumption persists over time without discontinuation for all products, which would presumably increase cumulative exposure to nicotine and potentially risk for dependence on one or more products.

Polyproduct users (27.1% of the sample) had moderate prevalence of past 6-month combustible cigarette, e-cigarette, and hookah use across the follow-up assessments, and displayed decreasing trajectories of e-cigarette (33% to 21% across follow-up) and hookah use (27% to 17% across follow-up) but increasing prevalence of combustible cigarette use (8% to 20% across follow-up). An appreciable proportion of adolescents initiate tobacco product use with e-cigarettes,^[@CIT0034],[@CIT0035]^ and use of e-cigarettes or hookah among noncigarette smoking youth is associated with combustible cigarette initiation in bi-variate analyses of associations of use of these products with combustible cigarette use.^[@CIT0022],[@CIT0036]^ The (nonchronic) polytobacco use trajectory identified in this study may be emblematic of such transitions and suggests temporary time limited use of hookah or e-cigarettes and with moderate risk of subsequent transition over to combustible cigarettes.

Extending extant cross-sectional data,^[@CIT0016],[@CIT0017],[@CIT0019],[@CIT0040]^ the three polytobacco use trajectory groups identified in this prospective study followed a risk gradient for engaging in substance use behaviors and reporting clinical levels of mental health symptomology with: (1) Chronic polyproduct users displaying the highest risk; (2) Polyproduct experimenters displaying moderate risk; and (3) Tobacco nonusers with the lowest risk. Research examining polytobacco use prior to when e-cigarettes and hookah were available or popular had studied concurrent use of combustible cigarettes and smokeless tobacco products and found strong associations between polytobacco use and substance use, with polytobacco users more than 30 times as likely to subsequently use alcohol, marijuana, and cocaine.^[@CIT0043]^ The results of the current study show that future substance use risk may also be elevated using diverse patterns of poly use of emerging tobacco products that are currently popular among adolescents.

Nicotine exposure during adolescence alters neurodevelopment and may increase vulnerability to substances of abuse^[@CIT0045]^ as well as impacting mood and mental health.^[@CIT0048]^ Given prior evidence that polytobacco use (vs. single product use) is positively associated with increased nicotine dependence,^[@CIT0005],[@CIT0049]^ and polytobacco users have been shown to engage in more frequent smoking and vaping than single-product users,^[@CIT0042]^ increased exposure to nicotine may confer risk for substance use and mental health symptomology. However, it is also possible that risk factors not accounted for in the current analysis explain the observed association between polytobacco use trajectories and substance use and mental health. Polytobacco use may be a risk marker for subsequent substance use and mental health problems with chronic polytobacco product users representing high-risk adolescents,^[@CIT0050]^ and less frequent polyproduct users being "lower-risk" teens with moderate levels of mental health and behavioral problems.

These findings could be used to inform interventions tailored to risky polyproduct user groups. For chronic polyproduct users, who present with the highest levels of subsequent and mental health problems, more intensive, multidimensional prevention programming (eg, mental health counseling in addition to substance use prevention/cessation programs) may be fruitful for preventing a myriad of adverse risk outcomes. For the larger segment of youth who experiment e-cigarettes and hookah primarily at the outset of high school (similar to the polyproduct users in this study), escalating combustible cigarette use risk may be a concern that warrants additional intervention focus as well as a considering programming to address the moderate increase in risk of substance use and mental health problems. Future research should examine potential mechanisms of protective factors for developing targeted interventions based on multidimensional characterizations of polytobacco product use. Also, consistent with prior research indicating that use of e-cigarettes and multiple tobacco products is prevalent in Hispanic youth,^[@CIT0004]^ we found that Hispanic youth constitute more than 50% of the Chronic polyproduct user and Polyproduct user groups. This finding reinforces the need for research focusing on tobacco-related health disparities among ethnic minority groups, particularly during adolescence.

Strengths of this study include the large and demographically diverse sample, repeated follow-up assessment strategy over a 2-year period, low attrition rate, modeling of complex patterns of comorbid tobacco trajectories, and adjustment for baseline outcomes as well as potential confounders. To minimize participant burden on students and schools, this study only included self-report measures, which can result in measurement limitations. Although the past 6-month use of each tobacco product was reported only as a binary outcome (yes/no), we also examined past 30-day frequency of product use where data was available---and these responses closely matched the past 6-month cigarette use prevalence (see [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Future research should utilize past 30-day frequency of tobacco product use in GMM models to capture greater variability in more frequent patterns of use. Additionally, e-cigarettes and hookah may contain variable amounts of nicotine,^[@CIT0045]^ and adolescents may not be aware if the e-cigarettes or hookah they are using contain nicotine;^[@CIT0051]^ hence, the extent to which these findings reflect targets for regulatory policy targeting products with nicotine is not known.

These limitations notwithstanding, the present study could serve as a methodological and conceptual template for future work investigating developmental patterns of polytobacco use among youth at a time of increasing diversity of tobacco products. More broadly, research like the current study that increases understanding of diverse developmental patterns of polytobacco use and their relations with subsequent health risks can inform researchers and policy makers regarding the prevalence and potential consequences of concurrent use of multiple tobacco products. If the associations demonstrated here were eventually determined to be causal, these results suggest that policy and prevention reducing the appeal of and access to various tobacco products may reduce the substance use and mental health burden in current and future generations of youth. In an increasingly diverse market place in which tobacco products and their use patterns are becoming more complex, it will be important to continue characterizing patterns of use and co-use of multiple tobacco products in ongoing surveillance of adolescents. As the marketplace and policy landscape continues to evolve, such evidence will be necessary to determine whether, amongst youth, polyproduct use remains the norm and increases risk of adverse substance use and mental health outcomes.

Supplementary Material {#s21}
======================

Supplementary data are available at *Nicotine & Tobacco Research* online.

###### 

Click here for additional data file.
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